Summary

The North America sterilization equipment market encompasses the machinery, technologies, and consumables such as steam autoclaves, low-temperature hydrogen peroxide gas plasma systems, ethylene oxide (EtO) sterilizers, and filtration units designed to eliminate transmissible agents from medical devices, instruments, and environments. Essential to maintaining sterility assurance, the market plays a critical role in preventing hospital-acquired infections (HAIs), protecting patient safety, and ensuring compliance across healthcare, pharmaceutical manufacturing, and food processing sectors. Growth in this regional market is primarily propelled by an aging population, rising volumes of complex surgical procedures, and a heightened emphasis on infection control standards. Furthermore, technological innovations particularly in eco-friendly and rapid low-temperature sterilization methods for heat-sensitive electronics and specialized medical instruments are expanding adoption while replacing traditional, hazardous EtO methods. Key industry associations active in this landscape include the Association for the Advancement of Medical Instrumentation (AAMI), the Association for Professionals in Infection Control and Epidemiology (APIC), and the Healthcare Sterile Processing Association (HSPA). These organizations drive market standards through critical activities such as developing technical quality guidelines, offering professional certification programs for sterilization technicians, establishing safety protocols alongside regulatory bodies like the U.S. FDA, and advocating for advanced infection prevention practices across North American healthcare systems. According to the research report, "North America Sterilization Equipment Market Outlook, 2031," published by Bonafide Research, the North America Sterilization Equipment Market was valued at more than 6.63 Billion in 2025.Key industry players driving regional activity include STERIS plc, Getinge AB, 3M Company, and Fortive Corporation (Advanced Sterilization Products). Recent strategic developments highlight aggressive portfolio consolidation; for instance, STERIS expanded its infection prevention holdings by acquiring surgical instrumentation and sterilization container lines from BD. Market opportunities are shifting rapidly away from traditional ethylene oxide (EtO) systems which face severe regulatory scrutiny and environmental challenges regarding toxicity toward eco-friendly, low-temperature alternatives like vaporized hydrogen peroxide (VHP) and nitrogen dioxide sterilizers. Additional growth lies in the integration of autonomous disinfection robotics and smart IoT tracking for central sterile supply departments (CSSDs) to minimize human error. From a supply chain perspective, the market relies heavily on specialized, multi-tiered networks. Raw material suppliers deliver high-grade stainless steel, heat-resistant polymers, and electronic control sensors to equipment manufacturers. Upstream supply chains frequently face bottlenecks due to specialized component lead times and volatile chemical reagent costs (e.g., medical-grade hydrogen peroxide). OEMs distribute final units directly to hospitals, ambulatory surgical centers, and pharmaceutical plants, while relying on regional third-party logistics and specialized field technicians for installation, calibration, and ongoing maintenance. Furthermore, localized contract sterilization service hubs play a vital role in buffer supply chains, preventing healthcare disruptions during equipment downtime. Market Drivers • Escalating rates of hospital-acquired infections (HAIs) and surgical volume: High patient admission rates across hospitals and ambulatory surgical centers (ASCs) in the U.S. and Canada directly drive the demand for continuous, high-volume sterilization. HAIs such as central line-associated bloodstream infections and surgical site infections impose significant financial penalties on healthcare providers through regulatory mandates and extended patient stays. Combined with an aging demographic requiring more surgical interventions, healthcare facilities are forced to continuously invest in advanced autoclaves, reprocessors, and automated washer-disinfectors to guarantee strict sterility standards. • Expanding biopharmaceutical manufacturing and complex drug delivery: North America remains a global hub for biopharmaceutical research and manufacturing. The surge in biologic therapies, cell and gene therapies, and mRNA-based vaccines requires ultra-clean production environments and specialized processing equipment. Because active pharmaceutical ingredients (APIs) and specialized containment vessels cannot tolerate biological contamination, contract manufacturing organizations (CMOs) and pharma giants are heavily investing in industrial-grade steam, radiation, and isolator sterilization units to ensure safety and regulatory compliance. Market Challenges • Regulatory overhaul and environmental phase-out of ethylene oxide (EtO): Ethylene Oxide (EtO) has historically served as the primary gaseous sterilant for heat- and moisture-sensitive single-use medical devices. However, stringent regulations from the U.S. Environmental Protection Agency (EPA) regarding EtO emissions and occupational air exposure are placing intense pressure on commercial sterilization plants. Facilities face potential closures, costly emission-abatement retrofits, and prolonged clearance cycles, causing supply chain bottlenecks for medical device manufacturers reliant on off-site processing. • High capital expenditure and operational costs for infrastructure upgrades: Advanced medical sterilization equipment such as vaporized hydrogen peroxide (VHP) chambers, automated endoscope reprocessors (AERs), and radiation sterilizers demands substantial initial capital investment. Beyond procurement, ongoing operational costs include specialized utility installation, routine chemical validation, high power consumption, and specialized technical labor. Small-to-midsize hospitals and outpatient clinics frequently struggle with capital allocations, leading to delayed equipment replacements and reliance on third-party service providers. Market Trends • Accelerated transition toward low-temperature and alternative sterilization technologies: Due to the rise of complex, heat-sensitive medical electronics, endoscopes, and polymer-based implants, traditional steam autoclaving is no longer suitable for all equipment. As a result, the market is shifting toward low-temperature methods like Vaporized Hydrogen Hydrogen Peroxide (VHP), Nitrogen Dioxide NO2, and Supercritical Carbon Dioxide CO2. These alternative modalities offer shorter cycle times, zero toxic residue, and enhanced compatibility with delicate components, making them the preferred choice for both hospitals and device manufacturers seeking alternatives to EtO. • Integration of IoT, automation, and real-time traceability software: Modern Central Sterile Supply Departments (CSSDs) are moving away from manual logging and paper tracking. Sterilization equipment is increasingly equipped with Internet of Things (IoT) connectivity, automated sensor monitoring, and tracking software. These systems automatically capture parameters like temperature, exposure time, pressure, and sterilant concentration, linking every sterilized tray directly to a specific patient or surgical theater. This digital shift reduces human error, provides immediate audit readiness, and enables predictive maintenance for healthcare equipment. Equipment is the largest segment by offering because healthcare facilities require dedicated, validated sterilization equipment to repeatedly process reusable critical instruments under controlled temperature, pressure, time, and monitoring conditions. Sterilization equipment forms the core physical infrastructure through which healthcare facilities convert validated sterilization procedures into routine, repeatable operations. In North America, particularly in the United States, hospitals, ambulatory surgical centers, dental facilities, outpatient clinics, and other healthcare settings routinely process reusable instruments that come into contact with sterile tissue or mucous membranes. The CDC identifies sterilization as essential because improperly processed instruments can transmit infectious pathogens to patients, making reliable sterilization capability a fundamental infection-prevention requirement rather than an optional service. The equipment itself is responsible for creating and controlling the conditions required for sterilization, including temperature, pressure, exposure time, steam quality, and, depending on the technology, other process variables. This requirement creates a recurring operational need for autoclaves, steam sterilizers, low-temperature sterilizers, monitoring systems, and associated processing equipment. Steam sterilizers are particularly important because the CDC states that most medical and surgical devices are heat stable and therefore undergo heat, primarily steam, sterilization. Equipment also has to support quality assurance through mechanical, chemical, and biological monitoring, which makes sterilization machinery closely connected with compliance and patient-safety procedures. FDA-recognized standards such as AAMI ST79 specifically address sterilization processing areas, staff practices, installation, maintenance, quality control, and quality improvement for steam sterilizers in healthcare facilities. In addition, FDA classifies steam sterilizers as regulated medical devices and recognizes standards covering hospital and tabletop steam sterilizers. Consequently, equipment remains central because facilities cannot achieve consistent sterilization simply by purchasing consumable sterilants or relying on procedural instructions; they need validated physical systems capable of delivering and documenting the required process. High-temperature or heat sterilization leads by technology because steam under pressure is highly effective, dependable, non-toxic, comparatively simple to monitor, and suitable for the large proportion of heat-stable medical and surgical instruments used in healthcare. High-temperature sterilization, especially moist heat through pressurized steam, has a particularly strong position because it aligns closely with the material characteristics of conventional reusable medical instruments. The CDC states that most medical and surgical devices used in healthcare facilities are made from heat-stable materials and therefore undergo heat, primarily steam, sterilization. For critical items that are resistant to heat and moisture, the CDC specifically identifies steam as the preferred sterilization method because of its reliability, consistency, and lethality. Steam sterilization also has several practical characteristics that make it well suited to routine healthcare operations. Saturated steam under pressure rapidly transfers heat to exposed surfaces and can penetrate medical packaging and device lumens when appropriate cycles and loading practices are followed. The CDC describes steam as non-toxic, inexpensive to operate relative to several alternatives, rapidly microbicidal and sporicidal, and relatively easy to control and monitor. Standard steam cycles commonly operate at temperatures such as 121°C or 132°C, with the required exposure period depending on the sterilizer, load configuration, packaging, and type of device. These defined physical parameters allow healthcare personnel to monitor the process using temperature, pressure, time, chemical indicators, and biological indicators. Heat sterilization is not universally appropriate because plastics, electronic components, delicate optics, and other heat- or moisture-sensitive products may require low-temperature alternatives such as ethylene oxide or vaporized hydrogen peroxide. FDA documentation recognizes multiple sterilization technologies for medical devices, including steam, dry heat, ethylene oxide, radiation, and vaporized hydrogen peroxide. Hospitals and clinics are the largest end-user segment because they perform continuous diagnostic, therapeutic, and surgical procedures that require frequent reprocessing of reusable medical instruments and strict infection-prevention controls. Hospitals and clinics represent the most natural concentration point for sterilization equipment because sterilization is directly integrated into everyday patient-care workflows. Surgical departments, operating rooms, procedure rooms, central sterile processing departments, outpatient treatment areas, dental services, and specialized clinical units all depend on appropriately processed instruments and devices. The CDC explains that instruments entering sterile tissue or the vascular system are critical items and must be sterile because contamination can result in disease transmission. Surgical instruments, biopsy forceps, and implanted medical devices are specifically identified among devices requiring sterilization when they are used in ways that breach protective barriers. This creates a recurring operational requirement within hospitals and clinics rather than an occasional need. The relationship becomes especially important because healthcare facilities must not only sterilize instruments but also clean them properly before sterilization, select an appropriate method, monitor the process, maintain equipment, document results, and store processed items appropriately. CDC recommendations call for steam sterilization of critical instruments that can tolerate heat, steam, pressure, and moisture, while low-temperature technologies are recommended for heat- or moisture-sensitive critical equipment. Hospitals also handle a broad range of procedures, meaning their sterilization departments typically need equipment capable of processing different load sizes, instrument configurations, packaging systems, and device materials. The U.S. healthcare environment further strengthens this requirement because surgical and invasive procedures occur across inpatient and outpatient settings. CDC data have documented millions of ambulatory surgical procedures and substantial activity in both hospitals and freestanding ambulatory surgery centers. Surgical instruments are the largest device-type segment because they are repeatedly used in invasive procedures, commonly require complete sterility, and many conventional instruments are made from materials that can withstand steam sterilization. Surgical instruments have a direct and unavoidable relationship with sterilization because they are frequently used to penetrate skin, enter sterile body tissues, contact blood, or otherwise cross natural protective barriers. The CDC classifies instruments that contact sterile body tissue or fluids as critical items and states that they should be sterile when used because microbial contamination can cause disease transmission. Examples specifically identified by the CDC include surgical instruments, biopsy forceps, and implanted medical devices. This classification creates a stronger sterilization requirement for surgical instruments than for many devices that only contact intact skin. Another important factor is material compatibility. A large proportion of traditional surgical instruments are manufactured from metals and other heat-resistant materials, allowing them to undergo steam sterilization repeatedly when the manufacturer's instructions and appropriate processing conditions are followed. The CDC recommends steam sterilization for critical medical and surgical instruments that are not damaged by heat, steam, pressure, or moisture. This makes surgical instruments particularly compatible with widely established autoclave infrastructure. Sterilization is also not a one-time activity for reusable instruments. Instruments used in one procedure must be appropriately cleaned, inspected, packaged or placed in suitable containers, sterilized, monitored, stored, and subsequently made available for another patient. The CDC notes that sterilization effectiveness depends on factors such as exposure conditions, instrument configuration, packaging, and the ability of sterilizing agents to reach relevant surfaces and lumens. The volume of invasive procedures further increases the operational importance of these instruments. CDC guidance notes that approximately 46.5 million surgical procedures and additional invasive medical procedures were performed annually in the United States in the context described by its sterilization guideline The United States is the largest North American region because it combines a very large healthcare delivery system with extensive surgical and outpatient procedure activity, established infection-control requirements, regulated medical-device processing, and widespread use of centralized sterilization infrastructure. The United States occupies a leading position within the North American sterilization equipment landscape because sterilization is embedded throughout a highly developed and extensively regulated healthcare system. U.S. healthcare facilities perform large numbers of invasive, surgical, diagnostic, and outpatient procedures, creating continuous requirements for sterile instruments and validated reprocessing processes. The CDC has reported that approximately 46.5 million surgical procedures, along with additional invasive medical procedures such as gastrointestinal endoscopies, are performed annually in the United States in the context of its healthcare sterilization guidance. Such activity creates substantial operational dependence on sterilization departments, autoclaves, low-temperature sterilizers, monitoring systems, instrument washers, and related processing infrastructure. The U.S. environment also places strong emphasis on documented infection prevention and process control. CDC recommendations specify when steam sterilization should be used, when low-temperature methods are necessary, and how sterilization processes should be monitored and controlled. At the regulatory level, the FDA regulates sterilization-related medical devices and recognizes technical standards covering hospital steam sterilizers, tabletop steam sterilizers, sterilization processes, and material compatibility. The United States also has a broad network of hospitals, ambulatory surgery centers, outpatient facilities, specialty clinics, dental practices, and medical-device manufacturers, giving sterilization equipment applications across both healthcare delivery and device production. Considered in this report • Historic Year: 2020 • Base year: 2025 • Estimated year: 2026 • Forecast year: 2031 Aspects covered in this report • Sterilization Equipment Market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Offering • Equipment • Services • Consumables & Accessories By Technology / Method • High-Temperature / Heat Sterilization(Steam / Moist Heat, Dry Heat) • Low-Temperature Sterilization (Ethylene Oxide (EtO), Hydrogen Peroxide Gas Plasma) • Radiation Sterilization • Filtration Sterilization By End User • Hospitals & Clinics (CSSD) • Medical Device Manufacturers • Pharmaceutical & Biotech • Food & Beverage • Others By Device Type • Surgical Instruments • Endoscopic Devices • Diagnostic Equipment • Disposable Medical Devices ***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents

Table of Contents

1. Executive Summary
2. Market Dynamics
2.1. Market Drivers & Opportunities
2.2. Market Restraints & Challenges
2.3. Market Trends
2.4. Supply chain Analysis
2.5. Policy & Regulatory Framework
2.6. Industry Experts Views
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. Market Structure
4.1. Market Considerate
4.2. Assumptions
4.3. Limitations
4.4. Abbreviations
4.5. Sources
4.6. Definitions
5. Economic /Demographic Snapshot
6. North America Sterilization Equipment Market Outlook
6.1. Market Size By Value
6.2. Market Share By Country
6.3. Market Size and Forecast, By Offering
6.4. Market Size and Forecast, By Technology / Method
6.5. Market Size and Forecast, By End User
6.6. Market Size and Forecast, By Device Type
6.7. United States Sterilization Equipment Market Outlook
6.7.1. Market Size by Value
6.7.2. Market Size and Forecast By Offering
6.7.3. Market Size and Forecast By Technology / Method
6.7.4. Market Size and Forecast By End User
6.8. Canada Sterilization Equipment Market Outlook
6.8.1. Market Size by Value
6.8.2. Market Size and Forecast By Offering
6.8.3. Market Size and Forecast By Technology / Method
6.8.4. Market Size and Forecast By End User
6.9. Mexico Sterilization Equipment Market Outlook
6.9.1. Market Size by Value
6.9.2. Market Size and Forecast By Offering
6.9.3. Market Size and Forecast By Technology / Method
6.9.4. Market Size and Forecast By End User
7. Competitive Landscape
7.1. Competitive Dashboard
7.2. Business Strategies Adopted by Key Players
7.3. Porter's Five Forces
7.4. Company Profile
7.4.1. Fortive Corporation
7.4.1.1. Company Snapshot
7.4.1.2. Company Overview
7.4.1.3. Financial Highlights
7.4.1.4. Geographic Insights
7.4.1.5. Business Segment & Performance
7.4.1.6. Product Portfolio
7.4.1.7. Key Executives
7.4.1.8. Strategic Moves & Developments
7.4.2. Getinge
7.4.3. STERIS
7.4.4. Steelco S.p.A.
7.4.5. Shinva Medical Instrument Co., Ltd.
7.4.6. Scitek Global Co., Ltd.
7.4.7. Labtron Equipment Ltd.
7.4.8. Labotronics Scientific
7.4.9. DE LAMA S.P.A.
7.4.10. HUMAN MEDITEK CO., LTD
7.4.11. SOLSTEO
7.4.12. Andersen Sterilizers
7.4.13. Renosem
7.4.14. Genist Technocracy Pvt. Ltd.
7.4.15. Bionics Scientific
7.4.16. Tuttnauer
7.4.17. MATACHANA
8. Strategic Recommendations
9. Annexure
9.1. FAQ`s
9.2. Notes
10. Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Figures

Figure 1: North America Sterilization Equipment Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 2: North America Sterilization Equipment Market Share By Country (2025)
Figure 3: United States Sterilization Equipment Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 4: Canada Sterilization Equipment Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 5: Mexico Sterilization Equipment Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 6: Porter's Five Forces of Global Sterilization Equipment Market


List of Tables

Table 1: Influencing Factors for Sterilization Equipment Market, 2025
Table 2: Top 10 Counties Economic Snapshot 2024
Table 3: Economic Snapshot of Other Prominent Countries 2022
Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 5: North America Sterilization Equipment Market Size and Forecast, By Offering (2020 to 2031F) (In USD Billion)
Table 6: North America Sterilization Equipment Market Size and Forecast, By Technology / Method (2020 to 2031F) (In USD Billion)
Table 7: North America Sterilization Equipment Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
Table 8: North America Sterilization Equipment Market Size and Forecast, By Device Type (2020 to 2031F) (In USD Billion)
Table 9: United States Sterilization Equipment Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 10: United States Sterilization Equipment Market Size and Forecast By Technology / Method (2020 to 2031F) (In USD Billion)
Table 11: United States Sterilization Equipment Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 12: Canada Sterilization Equipment Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 13: Canada Sterilization Equipment Market Size and Forecast By Technology / Method (2020 to 2031F) (In USD Billion)
Table 14: Canada Sterilization Equipment Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 15: Mexico Sterilization Equipment Market Size and Forecast By Offering (2020 to 2031F) (In USD Billion)
Table 16: Mexico Sterilization Equipment Market Size and Forecast By Technology / Method (2020 to 2031F) (In USD Billion)
Table 17: Mexico Sterilization Equipment Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 18: Competitive Dashboard of top 5 players, 2025